On February 18, 2025, the First Circuit Court of Appeals issued its decision in U.S. v. Regeneron Pharmaceuticals, ruling that the Anti-Kickback Statute (“AKS”) requires the government to prove that an AKS violation was the...more
On September 30, 2024, in U.S. ex rel. Zafirov v. Florida Medical Associates LLC, Judge Kathryn Mizelle in the Middle District of Florida dismissed a qui tam action under the False Claims Act (“FCA”) on the basis that the...more
10/3/2024
/ Appointments Clause ,
Article II ,
Dismissals ,
False Claims Act (FCA) ,
Florida ,
Fraud ,
Health Care Providers ,
Healthcare Fraud ,
Qui Tam ,
Relators ,
SCOTUS ,
Unconstitutional Condition ,
United States ex rel Polansky v Executive Health Resources Inc ,
Whistleblowers
This is the ninth in our 2024 Year in Preview series examining important trends in white collar law and investigations in the coming year...
The government had another busy year in 2023 investigating and prosecuting health...more
4/11/2024
/ CARES Act ,
Coronavirus/COVID-19 ,
Data Privacy ,
Department of Justice (DOJ) ,
Enforcement Actions ,
False Claims Act (FCA) ,
Fraud and Abuse ,
Health Care Providers ,
Healthcare ,
Healthcare Fraud ,
Opioid ,
Paycheck Protection Program (PPP) ,
Telemedicine ,
White Collar Crimes
Editors’ Note: This is the second in our start-of-year series examining important trends in white collar law and investigations in the coming year. Our previous entry discussed SEC enforcement in 2020. Up next: a look at...more
1/9/2020
/ Anti-Kickback Statute ,
Bribery ,
Compliance ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Enforcement Actions ,
False Claims Act (FCA) ,
Health Care Providers ,
Healthcare ,
Healthcare Fraud ,
Multidistrict Litigation ,
Pharmaceutical Industry ,
Physicians ,
Prescription Drugs ,
Securities and Exchange Commission (SEC) ,
State Attorneys General ,
White Collar Crimes